期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 20, 期 11, 页码 -出版社
MDPI
DOI: 10.3390/ijms20112698
关键词
mesenchymal stem cells; spinal cord injury; regenerative medicine; translational medicine
资金
- Ministero dell'Istruzione, dell'Universita e della Ricerca-MIUR project Dipartimenti di eccellenza [2018-2022]
Spinal cord injury (SCI) constitutes an inestimable public health issue. The most crucial phase in the pathophysiological process of SCI concerns the well-known secondary injury, which is the uncontrolled and destructive cascade occurring later with aberrant molecular signaling, inflammation, vascular changes, and secondary cellular dysfunctions. The use of mesenchymal stem cells (MSCs) represents one of the most important and promising tested strategies. Their appeal, among the other sources and types of stem cells, increased because of their ease of isolation/preservation and their properties. Nevertheless, encouraging promise from preclinical studies was followed by weak and conflicting results in clinical trials. In this review, the therapeutic role of MSCs is discussed, together with their properties, application, limitations, and future perspectives.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据